Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Other Working Capital Changes (2016 - 2025)

Immucell's Other Working Capital Changes history spans 15 years, with the latest figure at -$6659.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 89.65% year-over-year to -$6659.0; the TTM value through Dec 2025 reached $4318.0, up 104.64%, while the annual FY2025 figure was $4318.0, 104.64% up from the prior year.
  • Other Working Capital Changes reached -$6659.0 in Q4 2025 per ICCC's latest filing, up from -$52827.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $327569.0 in Q1 2023 to a low of -$395632.0 in Q2 2024.
  • Average Other Working Capital Changes over 5 years is -$4166.4, with a median of -$19452.5 recorded in 2021.
  • The largest YoY upside for Other Working Capital Changes was 3671.87% in 2021 against a maximum downside of 8423.22% in 2021.
  • A 5-year view of Other Working Capital Changes shows it stood at -$26487.0 in 2021, then plummeted by 806.13% to -$240007.0 in 2022, then skyrocketed by 94.84% to -$12386.0 in 2023, then plummeted by 419.68% to -$64367.0 in 2024, then surged by 89.65% to -$6659.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Other Working Capital Changes are -$6659.0 (Q4 2025), -$52827.0 (Q3 2025), and -$151911.0 (Q2 2025).